Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Phase Ib Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Doses of ZX2010 Injection in Chinese Nondiabetic Overweight or Obese Participants (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Double-Blind, Placebo-Controlled Phase Ib Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Doses of ZX2010 Injection in Chinese Nondiabetic Overweight or Obese Participants'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130393

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Yunnan Provincial Hospital of Traditional Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338065

Published by HT Digital Content Services with permission fr...